HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $2,552,000 | -49.9% | 130,290 | -48.2% | 0.01% | -52.2% |
| Q4 2017 | $5,091,000 | +180.5% | 251,300 | +140.5% | 0.02% | +155.6% |
| Q3 2017 | $1,815,000 | -62.0% | 104,500 | -62.1% | 0.01% | -43.8% |
| Q4 2015 | $4,773,000 | +14.8% | 275,400 | -11.0% | 0.02% | -27.3% |
| Q3 2015 | $4,157,000 | -60.8% | 309,600 | -34.1% | 0.02% | -65.1% |
| Q2 2015 | $10,613,000 | +253.9% | 470,000 | +123.8% | 0.06% | +173.9% |
| Q1 2015 | $2,999,000 | +216.7% | 210,000 | +181.9% | 0.02% | +187.5% |
| Q1 2014 | $947,000 | -41.6% | 74,500 | -31.1% | 0.01% | -27.3% |
| Q4 2013 | $1,622,000 | +20.0% | 108,200 | -11.6% | 0.01% | +266.7% |
| Q3 2013 | $1,352,000 | – | 122,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |